Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP8825 in Restless Legs Syndrome
NCT00530530Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gabapentin enacarbil in restless legs syndrome (RLS), sponsored by Astellas Pharma. Started Sep 2007; status: completed.
02
Drugs
gabapentin enacarbil
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00530530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00530530.